Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study.

Fatema Alzamanan, Yuan Ding, Adil Harroud
Author Information
  1. Fatema Alzamanan: The Neuro (Montreal Neurological Institute-Hospital), Montréal, Quebec, Canada.
  2. Yuan Ding: The Neuro (Montreal Neurological Institute-Hospital), Montréal, Quebec, Canada.
  3. Adil Harroud: The Neuro (Montreal Neurological Institute-Hospital), Montréal, Quebec, Canada. ORCID

Abstract

Obesity is implicated in the development of multiple sclerosis (MS), but its effect on disability is less well-established. This study examined the effects of various obesity measures on MS severity in 12,584 MS cases, using Mendelian randomization to mitigate confounding. Results showed a significant association between higher genetically-determined body mass index (N = 806,834) and increased MS severity (P = 0.02). This finding was supported by additional measures of general obesity but not adiposity distribution. The convergence of this genetic evidence with prior observational studies strengthens the association between obesity and adverse long-term disability in MS, suggesting weight management as a potential therapeutic strategy. ANN NEUROL 2024.

References

  1. Lancet Neurol. 2023 Jan;22(1):78-88 [PMID: 36410373]
  2. Neurology. 2009 Nov 10;73(19):1543-50 [PMID: 19901245]
  3. Brain. 2022 Sep 14;145(9):3147-3161 [PMID: 35104840]
  4. EClinicalMedicine. 2023 Mar 20;58:101882 [PMID: 36992862]
  5. J Alzheimers Dis. 2023;91(3):1059-1071 [PMID: 36565111]
  6. Mult Scler. 2022 Jul;28(8):1277-1285 [PMID: 34994579]
  7. Nat Rev Neurol. 2017 Jun;13(6):375-382 [PMID: 28303911]
  8. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):57-61 [PMID: 36319190]
  9. Int J Epidemiol. 2018 Feb 1;47(1):226-235 [PMID: 29040562]
  10. Mult Scler. 2021 Dec;27(14):2150-2158 [PMID: 33749377]
  11. Nature. 2023 Jul;619(7969):323-331 [PMID: 37380766]
  12. J Neurol. 2019 May;266(5):1182-1193 [PMID: 30820738]
  13. Nat Commun. 2020 Jan 17;11(1):376 [PMID: 31953392]
  14. Mult Scler. 2017 Dec;23(14):1938-1946 [PMID: 28155580]
  15. Autoimmun Rev. 2014 Sep;13(9):981-1000 [PMID: 25092612]
  16. Mult Scler. 2020 Sep;26(10):1237-1246 [PMID: 31161863]
  17. Nat Genet. 2020 Jul;52(7):740-747 [PMID: 32451458]
  18. Hum Mol Genet. 2019 Jan 1;28(1):166-174 [PMID: 30239722]
  19. Nat Rev Methods Primers. 2022 Feb 10;2: [PMID: 37325194]

Grants

  1. 349722/Fonds de Recherche du Québec - Santé
  2. 358114/Fonds de Recherche du Québec - Santé
  3. /Brain Canada Foundation

Word Cloud

Created with Highcharts 10.0.0MSobesityObesitydisabilitymeasuresseverityMendelianassociationimplicateddevelopmentmultiplesclerosiseffectlesswell-establishedstudyexaminedeffectsvarious12584casesusingrandomizationmitigateconfoundingResultsshowedsignificanthighergenetically-determinedbodymassindexN = 806834increasedP = 002findingsupportedadditionalgeneraladipositydistributionconvergencegeneticevidencepriorobservationalstudiesstrengthensadverselong-termsuggestingweightmanagementpotentialtherapeuticstrategyANNNEUROL2024MultipleSclerosisSeverity:RandomizationStudy

Similar Articles

Cited By